Psychiatry and Neurology, Neurology · Fayetteville, GA
NPI
1447211149
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
5
Medicare group memberships
Hospitals
5
Hospital affiliations
115 Sumner Rd Fl 2
Fayetteville, GA, 30214
Phone (770) 716-1562
Groups this clinician bills Medicare through
Medicare paid, 2024
$334K
16,057 services
Medicare patients, 2024
1,295
Average age 76
Drug cost, 2024
$5.8M
13,849 prescriptions
Company payments, 2025
$3,263
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Virendra V Ranadive was code J0585 (injection, onabotulinumtoxina, 1 unit), 12,801 times for 22 patients. In total Virendra V Ranadive billed 16,057 services in 32 codes, and Medicare paid $334K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 12,801 | 22 | $4.97 | $64K |
| 99214 Office E&M - Established | Office | 969 | 694 | $88.17 | $85K |
| 99213 Office E&M - Established | Office | 839 | 634 | $60.40 | $51K |
| 99204 Office E&M - New | Office | 360 | 360 | $113.14 | $41K |
| 95816 Neurologic | Office | 102 | 99 | $301.46 | $31K |
| 95885 Electrical Nerve Conductivity | Office | 64 | 59 | $46.74 | $2,991 |
| 99212 Office E&M - Established | Office | 54 | 28 | $37.36 | $2,018 |
| 99203 Office E&M - New | Office | 46 | 46 | $83.17 | $3,826 |
| 99215 Office E&M - Established | Office | 46 | 46 | $129.25 | $5,946 |
| 64615 Musculoskeletal | Office | 35 | 11 | $117.73 | $4,120 |
| 95911 Electrical Nerve Conductivity | Office | 34 | 33 | $163.89 | $5,572 |
| 95913 Electrical Nerve Conductivity | Office | 25 | 23 | $221.26 | $5,531 |
| 95910 Electrical Nerve Conductivity | Office | 22 | 22 | $111.75 | $2,458 |
| 99442 Telephone Services | Office | 15 | 15 | $65.75 | $986 |
By year: 2022 $209K for 4,495 services; 2023 $296K for 11,021 services; 2024 $334K for 16,057 services.
Medicare prescription drug claims, 2024
In 2024, the drug Virendra V Ranadive prescribed most often to Medicare patients was Memantine Hcl, with 2,522 prescriptions and refills. In total Virendra V Ranadive wrote 13,849 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 2,522 | 5,441 | 761 | $63K |
| Clonazepam Generic | 871 | 972 | 173 | $2,888 |
| Divalproex Sodium Generic | 862 | 1,676 | 295 | $8,872 |
| Gabapentin Generic | 834 | 1,744 | 300 | $19K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 677 | 1,477 | 189 | $23K |
| Rivastigmine Rivastigmine Tartrate | 573 | 1,001 | 140 | $36K |
| Lamotrigine Generic | 553 | 1,061 | 165 | $6,545 |
| Escitalopram Oxalate Generic | 528 | 1,061 | 170 | $4,716 |
| Levetiracetam Generic | 495 | 1,235 | 143 | $17K |
| Donepezil Hcl Generic | 414 | 1,036 | 143 | $4,237 |
| Lacosamide Generic | 409 | 637 | 73 | $42K |
| Pregabalin Generic | 323 | 511 | 89 | $7,558 |
| Primidone Generic | 298 | 690 | 94 | $9,120 |
| Quetiapine Fumarate Generic | 259 | 492 | 83 | $2,673 |
| Topiramate Generic | 218 | 514 | 78 | $2,428 |
Brand drugs: 982 claims; generic drugs: 12,842 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Virendra V Ranadive $3,263 ($3,263 in general payments such as food, travel and fees) from 35 companies. The largest payer was UCB, Inc. with $388.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 16 | $388 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $258 |
| Pfizer Inc. PFE | 16 | $232 |
| Abbvie Inc. ABBV | 21 | $218 |
| Janssen Biotech, Inc. JNJ | 4 | $189 |
| Amneal Pharmaceuticals LLC AMRX | 10 | $174 |
| Teva Pharmaceuticals USA, Inc. TEVA | 10 | $169 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $156 |
| Alexion Pharmaceuticals, Inc. AZN | 7 | $139 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 5 | $127 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.